{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:14:03Z","timestamp":1789384443233,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,29]],"date-time":"2018-03-29T00:00:00Z","timestamp":1522281600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003769","name":"Eisai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["epilepsybehavior.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.yebeh.2018.03.029","type":"journal-article","created":{"date-parts":[[2018,4,10]],"date-time":"2018-04-10T03:41:21Z","timestamp":1523331681000},"page":"50-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Long-term effects of adjunctive perampanel on cognition in adolescents with partial seizures"],"prefix":"10.1016","volume":"83","author":[{"given":"Jesus E.","family":"Pi\u00f1a-Garza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieven","family":"Lagae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Villanueva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Ben","family":"Renfroe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Laurenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betsy","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7471-882X","authenticated-orcid":false,"given":"Kimford J.","family":"Meador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2018.03.029_bb0005","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1111\/j.1528-1167.2006.00894.x","article-title":"Seizures and antiepileptic drugs: does exposure alter normal brain development?","volume":"47","author":"Marsh","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2018.03.029_bb0010","first-page":"682","article-title":"Epilepsy and neuropsychological comorbidities","volume":"19","author":"Rudzinski","year":"2013","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.yebeh.2018.03.029_bb0015","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/21622965.2013.839605","article-title":"Attention and executive functions in children with epilepsy: what, why, and what to do","volume":"3","author":"MacAllister","year":"2014","journal-title":"Appl Neuropsychol Child"},{"key":"10.1016\/j.yebeh.2018.03.029_bb0020","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1080\/13803395.2015.1024103","article-title":"Cognition in school-aged children with \"active\" epilepsy: a population-based study","volume":"37","author":"Reilly","year":"2015","journal-title":"J Clin Exp Neuropsychol"},{"key":"10.1016\/j.yebeh.2018.03.029_bb0025","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1528-1157.1997.tb01074.x","article-title":"Epilepsy in the developing brain: lessons from the laboratory and clinic","volume":"38","author":"Holmes","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2018.03.029_bb0030","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1212\/01.wnl.0000210503.89488.88","article-title":"Use of antiepileptic drugs and risk of fractures: case\u2013control study among patients with epilepsy","volume":"66","author":"Souverein","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2018.03.029_bb0035","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/1471-2431-13-211","article-title":"The impact of the use of antiepileptic drugs on the growth of children","volume":"13","author":"Lee","year":"2013","journal-title":"BMC Pediatr"},{"issue":"Suppl. 4","key":"10.1016\/j.yebeh.2018.03.029_bb0040","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1528-1157.44.s4.3.x","article-title":"Newer antiepileptic drugs and cognitive issues","volume":"44","author":"Aldenkamp","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2018.03.029_bb0045","author":"European Medicines Agency (EMA)"},{"key":"10.1016\/j.yebeh.2018.03.029_bb0050","author":"Food and Drug Administration (FDA)"},{"key":"10.1016\/j.yebeh.2018.03.029_bb0055","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/epi.13279","article-title":"Cognitive effects of adjunctive perampanel for partial-onset seizures: a randomized trial","volume":"57","author":"Meador","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2018.03.029_bb0060","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","article-title":"A power primer","volume":"112","author":"Cohen","year":"1992","journal-title":"Psychol Bull"},{"key":"10.1016\/j.yebeh.2018.03.029_bb0065","series-title":"Radiographic atlas of skeletal development of the hand and wrist","author":"Greulich","year":"1959"},{"key":"10.1016\/j.yebeh.2018.03.029_bb0070","series-title":"Growth at adolescence; with a general consideration of the effects of hereditary and environmental factors upon growth and maturation from birth to maturity","author":"Tanner","year":"1962"},{"key":"10.1016\/j.yebeh.2018.03.029_bb0075","series-title":"Wyllie's treatment of epilepsy: principles & practice","article-title":"Cognitive effects of epilepsy and its treatments","author":"Meador","year":"2015"},{"key":"10.1016\/j.yebeh.2018.03.029_bb0080","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1684\/epd.2016.0817","article-title":"Psychiatric and behavioural disorders in children with epilepsy (ILAE Task Force Report): adverse cognitive and behavioural effects of antiepileptic drugs in children","volume":"18","author":"Aldenkamp","year":"2016","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.yebeh.2018.03.029_bb0085","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1212\/WNL.0b013e3182a9f3ca","article-title":"Pretreatment cognitive deficits and treatment effects on attention in childhood absence epilepsy","volume":"81","author":"Masur","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2018.03.029_bb0090","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.yebeh.2016.05.013","article-title":"Cognitive phenotypes in childhood idiopathic epilepsies","volume":"61","author":"Hermann","year":"2016","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2018.03.029_bb0095","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1528-1157.1986.tb03607.x","article-title":"Behavioral characteristics of epilepsy patients compared with normal controls","volume":"27","author":"Smith","year":"1986","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2018.03.029_bb0100","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1212\/01.WNL.0000115653.82763.07","article-title":"Cognitive side effects of antiepileptic drugs in children","volume":"62","author":"Loring","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2018.03.029_bb0105","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1542\/peds.80.2.165","article-title":"Psychologic and behavioral effects of antiepileptic drugs in children: a double-blind comparison between phenobarbital and valproic acid","volume":"80","author":"Vining","year":"1987","journal-title":"Pediatrics"},{"key":"10.1016\/j.yebeh.2018.03.029_bb0110","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1469-8749.1991.tb14917.x","article-title":"Cognitive impairment in new cases of epilepsy randomly assigned to carbamazepine, phenytoin and sodium valproate","volume":"33","author":"Forsythe","year":"1991","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.yebeh.2018.03.029_bb0115","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.seizure.2007.05.006","article-title":"The cognitive effects of oxcarbazepine versus carbamazepine or valproate in newly diagnosed children with partial seizures","volume":"16","author":"Donati","year":"2007","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2018.03.029_bb0120","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJMoa0902014","article-title":"Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy","volume":"362","author":"Glauser","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2018.03.029_bb0125","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s40272-016-0187-z","article-title":"The cognitive profile of ethosuximide in children","volume":"18","author":"IJff","year":"2016","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.yebeh.2018.03.029_bb0130","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1177\/08830738050200030801","article-title":"Clinical experience with zonisamide monotherapy and adjunctive therapy in children with epilepsy at a tertiary care referral center","volume":"20","author":"Kim","year":"2005","journal-title":"J Child Neurol"},{"key":"10.1016\/j.yebeh.2018.03.029_bb0135","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.pediatrneurol.2005.10.007","article-title":"Efficacy and safety of zonisamide monotherapy in a cohort of children with epilepsy","volume":"34","author":"Kothare","year":"2006","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2018.03.029_bb0140","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/epi.12548","article-title":"Adjunctive zonisamide therapy in the long-term treatment of children with partial epilepsy: results of an open-label extension study of a phase III, randomized, double-blind, placebo-controlled trial","volume":"55","author":"Guerrini","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2018.03.029_bb0145","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1111\/j.1528-1167.2009.02197.x","article-title":"Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial","volume":"50","author":"Levisohn","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2018.03.029_bb0150","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1177\/0883073811417183","article-title":"A long-term open-label extension study assessing cognition and behavior, tolerability, safety, and efficacy of adjunctive levetiracetam in children aged 4 to 16years with partial-onset seizures","volume":"27","author":"Schiemann-Delgado","year":"2012","journal-title":"J Child Neurol"},{"key":"10.1016\/j.yebeh.2018.03.029_bb0155","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/epi.13417","article-title":"Adjunctive perampanel in adolescents with inadequately controlled partial-onset seizures: a randomized study evaluating behavior, efficacy, and safety","volume":"57","author":"Lagae","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2018.03.029_bb0160","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/epi.12643","article-title":"Long-term safety of perampanel and seizure outcomes in refractory partial-onset seizures and secondarily generalized seizures: results from phase III extension study 307","volume":"55","author":"Krauss","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2018.03.029_bb0165","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.yebeh.2015.06.025","article-title":"The bone mineral content alterations in pediatric patients medicated with levetiracetam, valproic acid, and carbamazepine","volume":"51","author":"Serin","year":"2015","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2018.03.029_bb0170","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1212\/WNL.0b013e3182635735","article-title":"Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304","volume":"79","author":"French","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2018.03.029_bb0175","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1528-1167.2012.03638.x","article-title":"Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: results of randomized global phase III study 305","volume":"54","author":"French","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2018.03.029_bb0180","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1212\/WNL.0b013e318254473a","article-title":"Randomized phase III study 306: adjunctive perampanel for refractory partial-onset seizures","volume":"78","author":"Krauss","year":"2012","journal-title":"Neurology"},{"issue":"14 Supplement","key":"10.1016\/j.yebeh.2018.03.029_bb0185","article-title":"Effect of adjunctive perampanel on growth and development in adolescents with inadequately controlled partial seizures","volume":"84","author":"Pina-Garza","year":"2015","journal-title":"Neurology"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505018300921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505018300921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T21:30:49Z","timestamp":1720215049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505018300921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":37,"alternative-id":["S1525505018300921"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2018.03.029","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term effects of adjunctive perampanel on cognition in adolescents with partial seizures","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2018.03.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}